![]() |
![]() |
![]() |
|||
![]()
|
Issues archive
|
![]() Evonik Industries AG refinanced its existing syndicated credit facility with a group of 18 banks securing improved conditions. The new credit facility with an unchanged volume of €1.75 billion has a term of 5 years with the option of two extensions of one year each and will end in 2024 at the latest. The credit facility serves the Group’s central liquidity reserve. With this refinancing, Evonik is benefitting from the current positive market environment for companies with a solid investment grade rating, securing financial flexibility and independence for the coming years. Ute Wolf, Chief Financial Officer at Evonik, says: “All invited banks decided to participate in the financing. This underlines the banking sector’s trust in Evonik as a long-term and reliable partner.” Peter Schallenberg, head of Finance at Evonik, adds: “With the refinancing, we made use of the current good market environment, securing our central liquidity reserve in the long term.” A total of 18 banks from Germany (6), the U.S. (4), Great Britain (2), France (2), Japan, China, Italy, and Switzerland (1 each) participated in the financing. Mandated Lead Arrangers & Bookrunners: Bank of America Merrill Lynch, Barclays, BayernLB, BNP Paribas, Citi, Commerzbank, Credit Suisse, Deutsche Bank, DZ Bank, Goldman Sachs, ICBC, Landesbank Hessen-Thüringen GZ, HSBC, J.P. Morgan, Landesbank Baden-Württemberg, Mizuho, Société Générale, UniCredit. The transaction was prepared and led by Commerzbank as the coordinating bank.
All rights reserved. No information from the web site may be reproduced without the permission of the magazine's editorial board.
© Eurasian chemical market, 2005-2023 |
|||